Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -84.55% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -84.55% | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -84.55% | -- | -- | -- | |
| SG&A Expenses | 273.15% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 188.47% | -- | -- | -- | |
| Operating Income | -243.33% | -- | -- | -- | |
| Income Before Tax | -218.05% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -218.10% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -218.10% | -- | -- | -- | |
| EBIT | -243.33% | -- | -- | -- | |
| EBITDA | -198.48% | -- | -- | -- | |
| EPS Basic | -19.25% | -- | -- | -- | |
| Normalized Basic EPS | -7.17% | -- | -- | -- | |
| EPS Diluted | -19.25% | -- | -- | -- | |
| Normalized Diluted EPS | -7.17% | -- | -- | -- | |
| Average Basic Shares Outstanding | 138.84% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 138.84% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
